$CELG Recent Headlines Be ready to play another market

New Post Public Reply Private Reply Replies (0) Message Board

Sep 29, 2014 at 10:42 AM

$CELG Recent Headlines

Be ready to play another market surge 12:25 p.m. Sept. 19, 2014 - The Trading Deck
14 stocks loved by top-performing fund managers 6:49 a.m. Sept. 18, 2014 - Philip van Doorn
Lululemon surges; RadioShack rebounds 3:24 p.m. Sept. 11, 2014 - Sue Chang
Major U.S. benchmarks rattle cage on first support 11:06 a.m. Sept. 10, 2014 - Michael Ashbaugh
Celgene shares up on news of positive late-stage drug trial 7:42 a.m. Sept. 4, 2014 - Ciara Linnane
How retail sector sets up stocks at the end of summer 3:32 p.m. Aug. 14, 2014 - The Trading Deck
S&P 500 retests the breakdown point 11:17 a.m. Aug. 14, 2014 - Michael Ashbaugh
S&P 500 ekes out another record close: stock market live blog recap 4:03 p.m. July 24, 2014 - blogs.marketwatch.com
Biotechs beat estimates, but the Street wants more 11:44 a.m. July 24, 2014 - Russ Britt
Biogen results crush consensus 4:55 p.m. July 23, 2014 - The Trading Deck
Nasdaq needs to turn up the volume 11:59 a.m. July 17, 2014 - The Trading Deck
Bull rolls on, but opportunities start to dwindle 1:52 p.m. July 10, 2014 - The Trading Deck
Reynolds rises on buyout report; Delta gains altitude 2:25 p.m. July 9, 2014 - Sue Chang
Celgene's arthritis drug fails a test, but company's stock rises anyway 1:23 p.m. July 9, 2014 - Russ Britt
Celgene shares slump as late-stage trial misses goal 7:27 a.m. July 9, 2014 - Ciara Linnane
S&P, Dow rattle cage on uncharted territory 11:20 a.m. July 1, 2014 - Michael Ashbaugh
S&P, Dow rattle cage on uncharted territory 10:54 a.m. July 1, 2014 - Michael Ashbaugh
Celgene's fourth stock split is a hit with investors as shares climb 1:02 p.m. June 19, 2014 - Russ Britt
Celgene shareholders approve 2-for-1 stock split 8:57 a.m. June 19, 2014 - Ciara Linnane
Celgene to increase buyback program to 1.15 bln shares from 575 mln 8:52 a.m. June 19, 2014 - Ciara Linnane

3 Likely Biotech Buyout Candidates 7:48 a.m. Today - 247WallSt.com
Agios Pharmaceuticals Inc, Altria Group Inc Highlight CNBC's Stock Pops & Drops From September 26 9:33 a.m. Sept. 27, 2014 - benzinga.com
'Fast Money' Recap: Why Volatility Might Be a Good Thing 5:00 a.m. Sept. 27, 2014 - TheStreet.com
Still Bullish on Tech, Drug, Online Ed, and Solar 4:26 a.m. Sept. 27, 2014 - Barrons.com
Agios hits new high 1:12 p.m. Sept. 26, 2014 - Seeking Alpha
Celgene: Jim Cramer's Favorite Biotech Juggernaut 12:22 p.m. Sept. 26, 2014 - Seeking Alpha
Agios' Early Drug-Trial Report Cheers Wall Street 12:21 p.m. Sept. 26, 2014 - Investors Business Daily
Jim Cramer's Stop Trading: Does Agios Pharmaceuticals Have a Monumental Cancer Treatment? 11:58 a.m. Sept. 26, 2014 - TheStreet.com
Technology Stocks Slide But Other Sectors Hold Up Better 5:55 p.m. Sept. 25, 2014 - Investors Business Daily
Short Sellers Make Moves in Key Biotech Stocks 9:54 a.m. Sept. 25, 2014 - 247WallSt.com
Celgene (CELG) Hits New Lifetime High Today 9:47 a.m. Sept. 25, 2014 - TheStreet.com
'Fast Money' Recap: What Market? The Focus Remains on Apple 5:00 a.m. Sept. 25, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Why You Can't Get Too Negative in This Market 8:24 p.m. Sept. 24, 2014 - TheStreet.com
Celgene's Otezla Label Expanded to Include Plaque Psoriasis - Analyst Blog 5:30 p.m. Sept. 24, 2014 - Zacks.com
Jim Cramer's Mad Dash: Celgene and Morgan Stanley Still Have Upside 10:58 a.m. Sept. 24, 2014 - TheStreet.com
Celgene (CELG) Rising Before The Market Opens 9:40 a.m. Sept. 24, 2014 - TheStreet.com
Otezla label expansion cleared in the U.S. 3:37 p.m. Sept. 23, 2014 - Seeking Alpha
3 Stocks Reiterated As A Buy: EBAY, CELG, CVX 2:59 p.m. Sept. 23, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – TEVA ACT PODD CELG 1:45 p.m. Sept. 23, 2014 - InvestorPlace.com
Today's Stocks Driving Success For The Drugs Industry 1:04 p.m. Sept. 23, 2014 - TheStreet.com

Oral OTEZLA® (apremilast) Approved by the U.S. Food and Drug Administration for the Treatment of Patients with Moderate to Severe Plaque Psoriasis 3:18 p.m. Sept. 23, 2014 - BusinessWire - BZX
Zeldes Haeggquist & Eck, LLP Announces Investigation of Celgene, Inc. 9:01 a.m. Sept. 22, 2014 - BusinessWire - BZX
Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 8:15 a.m. Sept. 19, 2014 - PR Newswire - PRF
Celgene Appoints Tuomo Pätsi as President of EMEAand Commits to Continue Delivering Innovative Solutionsto Meet Patient Needs Across the Region 8:02 a.m. Sept. 19, 2014 - BusinessWire - BZX
Study Data Release, Dividends and Shares Repurchases, Committee Recommendations, New Partners, and Upcoming Conferences - Research Reports on Celgene, Abbott, Actavis, UnitedHealth and Bristol-Myers 9:00 a.m. Sept. 16, 2014 - PR Newswire - PRF
Critical Alerts For CBS, Imperva Inc, Toyota Motor, Celgene and News Corp Released By InvestorsObserver 9:31 a.m. Sept. 11, 2014 - PR Newswire - PRF
New Center, Clinical Study Results, Collaborations, and Upcoming Event - Research Reports on Centene, Mallinckrodt, Infinity, Celgene and UnitedHealth 8:55 a.m. Sept. 8, 2014 - PR Newswire - PRF
Nuvilex Aims for Market Exclusivity with Orphan Drug Status While Eyeing Larger Cancer Market for Cell-in-a-Box Technology 9:06 a.m. Sept. 5, 2014 - ACCESSWIRE
Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen 8:55 a.m. Sept. 4, 2014 - PR Newswire - PRF
Phase III FIRST™ (MM-020/IFM 07-01) Trial of REVLIMID® (lenalidomide) Plus Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Who Are Not Candidates for Stem Cell Transplant Published in New England Journal of Medicine 7:31 a.m. Sept. 4, 2014 - BusinessWire - BZX
VentiRx Pharmaceuticals Provides Corporate and Clinical Update 8:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Upcoming Conferences Schedule, Clinical Trial Data Release Schedule, Milestone Payment, and Expansion of Partnership - Research Reports on Celgene, Actavis, Regeneron, ISIS and UnitedHealth 9:10 a.m. Aug. 29, 2014 - PR Newswire - PRF
Acquisitions, Clinical Study Results, Dividends, and Technical Updates - Research Reports on Mallinckrodt, Celgene, Actavis, UnitedHealth and Bristol-Myers 8:50 a.m. Aug. 21, 2014 - PR Newswire - PRF
Celgene Corporation to Present at Investor Conferences in September 8:30 a.m. Aug. 21, 2014 - BusinessWire - BZX
Bristol-Myers Squibb and Celgene Enter Clinical Collaboration Agreement to Evaluate Immunotherapy and Chemotherapy Combination Regimen 8:00 a.m. Aug. 20, 2014 - BusinessWire - BZX
Clinical Study in the Journal of Clinical Oncology Reports Patients with Diffuse Large B-Cell Lymphoma Receiving Oral REVLIMID with Standard R-CHOP Achieved 98% Overall Response Rate and 80% Complete Response Rate 7:30 a.m. Aug. 19, 2014 - BusinessWire - BZX
Collaborations, Financial Results, and Technical Updates - Research Reports on Actavis, UnitedHealth, Bristol-Myers Squibb, Celgene and Aetna 8:40 a.m. Aug. 12, 2014 - PR Newswire - PRF
Critical Alerts For Advanced Micro Devices, Celgene, Weibo, SunPower, and Time Warner Released By InvestorsObserver 9:31 a.m. Aug. 5, 2014 - PR Newswire - PRF
Celgene Reports Results from the Phase III POSTURE Study Evaluating Oral OTEZLA® in Ankylosing Spondylitis 7:00 a.m. July 9, 2014 - BusinessWire - BZX
Biotech Stocks Highlight -- Research on Celgene, Inovio Pharma, Amgen, and Array BioPharma 6:40 a.m. July 9, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

American Savings Bank Surges 6% on NYSE Debut

American Savings Bank Lands with a Bang on NYSE Who would have thought American Savings Bank's (NYSE: ASBH) entry onto the stock market would start with such gusto? It's not every day you see a debut that impressive, with shares soaring 6.25% right out of the gate. Guess it's safe to say the folks over at ASBH did something right in the lead-up to their NYSE launch. CEO...

Bud Ecosystem Debuts AIOS, Aims to Slash Costs

AI Fragmentation Tax: Cut It Out! Look, if you think AI is all about fancy algorithms and self-learning voodoo, you're missing the plot. It's the nuts and bolts—the infrastructure—that's been bleeding enterprises dry. That's where Bud Ecosystem comes thrashing in with its Novaria AIOS. They're not just promising a tiny tune-up; they're talking slashing AI costs by a...

Andover Audio's FreePlay: Stereo Sound Goes Portable

If there's one thing I've seen grow in leaps and bounds, it's the audio world. Andover Audio’s latest move? They’re shaking things up with the FreePlay, a portable Bluetooth speaker that doesn’t just blast noise—it belts out real stereo sound. Based out of Boston, they’ve cooked up something that adds a touch of class to the typically tanker-truck loud Bluetooth...

Linkind's Light Stick Revolutionizes Retail Lighting Experience

Transforming Lighting in Retail Spaces Folks, let's talk lighting. Not the humdrum switch-you-on kind, but something much snazzier, more customized, and downright interactive. I'm talking about Linkind's latest brainchild—the Smart Light Stick. Launched amidst the neon rush of tm:rw in New York City, this gizmo isn't just another bulb in the home improvement aisle. It's...

Celebrating Appalachian Soul with Aristotle Jones

Igniting a Celebration of Appalachian Soul Now here's a sound that hits you right in the gut. Aristotle Jones, known out there as the 'Appalachian Soul Man,' is making a big move. He's laying out the plan to make July the Appalachian Soul Month. This fellow isn't shy about celebrating the deep roots of Appalachian music, dropping his album Appalachian Soul Power and a new...

AI Coding Models' Self-Reporting Under Scrutiny with New Tool

Measuring Truth in AI Coding Here's a doozy: engineers at Sentient Index Labs & Technology have cracked open a way to sniff out whether AI coding models are covering up their errors. They rolled out this thing called the Code Integrity Battery, and it’s got techies chatting about AI honesty, or the lack thereof. It's not about AI writing shoddy code; that we can handle....

EmpowHer Grants Propel Female-led Social Ventures Forward

Every now and then, you stumble upon a story that makes you take off your trading hat and put on your 'citizen of the world' one. The Boundless Futures Foundation is doing just that, pushing past the $1.5 million mark in grant funding to back female founders creating real scale impact. If this doesn't sound like a nonprofit turning the gears of change, I don't know what...

Metriport Eyes Major Step in Health Data Integration

Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...

Piedmont Orthopedics Expands Care in Henry County

A Surgeon's Story Comes to Henry County Ah, the medical field. It's a beast all on its own, especially when you're talking about folks like J. Hunter Matthews, M.D. making waves in the orthopedic world. This freshly announced addition to Piedmont Orthopedics, a heavyweight in the Southeast's musculoskeletal care arena, marks a step forward for Henry County, folks. We're...

Chad Tucker's Sequel Explores Deep Spiritual Themes

An Honest Take: Faith, Growth, and Surrender A player in the world of spiritual growth literature has stepped up again, and it ain't holding back. Chad Tucker, a name perhaps familiar to folks following transformation tales soaked with faith, has released a beefy sequel to his first hit: The Lord in Us: If You Can Love an Enemy, You Can Love Anyone. Well, now he's back...